Biochemical markers of myocardial remodelling in hypertensive heart disease (Q37258076)

19 August 2017

1 reference

title

Biochemical markers of myocardial remodelling in hypertensive heart disease (English)

1 reference

19 August 2017

Susana Ravassa

3

0 references

Begoña López

object named as

Begoña López

2

0 references

author name string

Arantxa González

1

1 reference

19 August 2017

Javier Beaumont

4

1 reference

19 August 2017

Teresa Arias

5

1 reference

19 August 2017

Nerea Hermida

6

1 reference

19 August 2017

Amaia Zudaire

7

1 reference

19 August 2017

Javier Díez

8

1 reference

19 August 2017

publication date

1 September 2008

1 reference

19 August 2017

published in

Cardiovascular Research

1 reference

19 August 2017

volume

81

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

509-518

1 reference

Development of heart failure in recent hypertension trials.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Biomarkers of cardiovascular disease: molecular basis and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

The cellular and molecular response of cardiac myocytes to mechanical stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Cardiomyocyte apoptosis in hypertensive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Annexin-mediated Ca2+ influx regulates growth plate chondrocyte maturation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Anisomycin superinduces annexin V mRNA expression through the ERK1/2 but not the p38 MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Annexins and Ca2+ handling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Annexin A5: an imaging biomarker of cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Fibrosis and hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

The role of myocardial fibrillar collagen in ventricular remodeling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Hypertrophy, Hyperplasia and Structural Dilatation of the Human Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Changes in extracellular collagen matrix alter myocardial systolic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Cardiotrophin-1 predicts death or heart failure following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Myocardial collagen turnover in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Cardiovascular proteomics: tools to develop novel biomarkers and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN235

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN235

1 reference

19 August 2017

1 reference